Clinical Trial Update: Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PTK 0796 for complicated skin and skin structure infection has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin Disease
• Complicated Skin and Skin Structure Infection
• Infectious Skin Disease

Drugs mentioned

• PTK 0796 (PTK 0796)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Infectious Skin Disease, Bacterial Skin Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-10-12